[Psycho-oncological interventions: What type of psychotherapeutic innovations?]
Interventions psycho-oncologiques : quelles approches innovantes ?
Communication
EMDR ACT
EMDR Acceptance and Commitment Therapy
Fear of recurrence
Interventions
Interventions psychothérapeutiques
Peur de la récidive
Psycho-oncologie
Psycho-oncology
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
29
10
2021
revised:
07
03
2022
accepted:
10
03
2022
pubmed:
9
5
2022
medline:
31
5
2022
entrez:
8
5
2022
Statut:
ppublish
Résumé
Psycho-oncology is evolving in line with oncology progress and increasing complexity, but also with change in cancer care organization. Alongside the more traditional psycho-oncological interventions, such as the support or verbal psychotherapy of various inspirations (psychodynamic, integrative, systemic, existential) and body-mediated approaches, that allow the patient to be accompanied throughout his/her cancer care trajectory, psycho-oncology is now benefiting from the development of more structured interventions, often brief and targeted at a specific situation or symptom. This article reviews three of these new psychotherapeutic approaches, which are largely developed in the Anglo-Saxon world: the management of fear of recurrence by CBT third wave strategies, ACT therapy or, more recently, EMDR to answer to psychotraumatic situations. We describe here the principles, the main indications in oncology patients and the expected clinical benefits. It also presents tools such as Questionnaire Prompt Lists for optimizing the communication between patients and health professionals, which constitute a psychotherapeutic intervention by itself.
Identifiants
pubmed: 35527072
pii: S0007-4551(22)00086-8
doi: 10.1016/j.bulcan.2022.03.001
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
548-556Informations de copyright
Copyright © 2022. Published by Elsevier Masson SAS.